JUL 30, 2018 11:00 AM PDT

Traumatic Childhood to Addiction, an Immune System Problem

WRITTEN BY: Caitlin Williams

Addiction is defined as the chronic, relapsing disorder characterized by compulsive drug seeking and use despite adverse consequences. Every year the misuse of alcohol, nicotine, and illicit drugs, and misuse of prescription drugs cost Americans more than $700 billion a year in health care costs, crime, and lost productivity. Annually drug and alcohol use contribute to the death of more than 90,000 Americans. Addiction, like other diseases, disrupts normal, healthy functioning organs in the body, and has serious harmful effects that are preventable and treatable in most cases. Traumatic childhood is one of the risk factors for developing an addiction, but the biological mechanisms that underlie this relationship are currently understudied. A recent study published in Biological Psychiatry looks at the link between adverse childhood experiences, the immune system, and the effects of psychostimulants in relation to addiction.

Children who experience adverse childhood events are 7 to 10-fold more likely to experience addiction to illicit drugs as adults. Studies have shown that childhood adversity influences all stages of addiction from initiation of drug consumption to long-term maintenance of the addicted state. Adverse childhood experiences can also influence the innate immune system and trigger an immune response. The immune system continues to develop after birth, which is influenced by the postnatal environment such as psychosocial stress in childhood. The use of psychostimulants affects the immune system and alters cognitive and behavioral changes, based on rodent studies. These drugs may elicit an inflammatory response or signal danger to the immune system leading to a neuroinflammatory response, while toll-like receptors in the innate immune response mediate the reinforcing and rewarding properties of drugs such as cocaine. The evidence linking traumatic childhood experiences with susceptibility to substance abuse, and possible mediation by the immune system, was further studied by Dr. Valeria Carola and her research group.

The study induced psychosocial stress in 2-week-old mice by exposing them to threatening male mice, followed by an examination of the brain immune cells of the mice in adulthood. The early stress altered the structure of the brain immune cells in a particular brain region associated with the reward system and drug-seeking, and increased response of the brain immune cells to cocaine. Effects of early social stress on the peripheral immune system included an increase in the release of inflammatory molecules from white blood cells, which was amplified by exposure to cocaine, compared to control mice. Blocking immune activation during early life stress in the mice, by use of pharmaceuticals, prevented the development of susceptibility to cocaine in adulthood. The mice who received this pharmaceutical during social stress did not show cellular changes or drug-seeking behaviors seen in non-treated mice.

On a genetic level, the study compared immune system function of 38 cocaine addicts and 20 healthy volunteers. The results showed that levels of gene expression essential for immune system function increased in those with childhood trauma, both in addicts and healthy volunteers. Individuals who experience childhood trauma and addiction had the highest levels of gene expression. This research adds to the evidence that adverse effects of early life trauma on brain development lead to complications into adulthood. "Our work emphasizes once again the importance of the emotional environment where our children are raised and how much a serene and stimulating environment can provide them with an extra 'weapon' against the development of psychopathologies," said Dr. Carola.

National Institute on Drug Abuse

 

About the Author
  • Caitlin holds a doctorate degree in Microbiology from the University of Georgia where she studied Mycoplasma pneumoniae and its glycan receptors. She received her Bachelor's in Biology from Virginia Tech (GO HOKIES!). She has a passion for science communication and STEM education with a goal to improve science literacy. She enjoys topics related to human health, with a particular soft spot for pathogens.
You May Also Like
MAR 04, 2021
Infographics
All You Need to Know about COVID-19 Vaccines
MAR 04, 2021
All You Need to Know about COVID-19 Vaccines
After over a year lockdowns brought on by the pandemic, hopes for returning to something even similar to ' ...
APR 22, 2021
Drug Discovery & Development
mRNA Covid Vaccines May Protect Against New Strains and Common Cold
APR 22, 2021
mRNA Covid Vaccines May Protect Against New Strains and Common Cold
Researchers from Johns Hopkins have found that the mRNA Covid vaccines developed by Pfizer and Moderna not only work wit ...
MAY 13, 2021
Immunology
Salmonella Vaccine Uses "Molecular Telephones" to Talk to the Immune System
MAY 13, 2021
Salmonella Vaccine Uses "Molecular Telephones" to Talk to the Immune System
Salmonella infections are a massive problem—Over 95 million people are affected by this foodborne illness every ye ...
MAY 17, 2021
Cell & Molecular Biology
Survey Results: Where Is Pluripotent Stem Cell Research Now?
MAY 17, 2021
Survey Results: Where Is Pluripotent Stem Cell Research Now?
Human pluripotent stem cell (hPSC) lines are now commonly used across the globe. In the lab, researchers rely on hPSCs t ...
JUN 15, 2021
Clinical & Molecular DX
An Early Warning System for Type 1 Diabetes in Children
JUN 15, 2021
An Early Warning System for Type 1 Diabetes in Children
In type 1 diabetes, or T1D, the body’s own immune system mistakenly launches an aggressive attack on insulin-produ ...
JUN 16, 2021
Immunology
Researchers Identify a Novel COVID Therapeutic Target and Mortality Predictor
JUN 16, 2021
Researchers Identify a Novel COVID Therapeutic Target and Mortality Predictor
Researchers at King’s College London have discovered a new antiviral target to combat COVID-19: the galectin-3-bin ...
Loading Comments...